Colesevelam: Revision history

20 March 2015

• curprev 16:2516:25, 20 March 2015‎ Kiran Singh talk contribs‎ 64,602 bytes −8‎ No edit summary

18 March 2015

• curprev 16:2416:24, 18 March 2015‎ Gerald Chi talk contribs‎ m 64,610 bytes −16‎ No edit summary
• curprev 16:2316:23, 18 March 2015‎ Gerald Chi talk contribs‎ m 64,626 bytes +8‎ No edit summary
• curprev 16:2216:22, 18 March 2015‎ Gerald Chi talk contribs‎ m 64,618 bytes +1‎ No edit summary
• curprev 16:0416:04, 18 March 2015‎ Kiran Singh talk contribs‎ 64,617 bytes −64‎ No edit summary
• curprev 16:0116:01, 18 March 2015‎ Kiran Singh talk contribs‎ 64,681 bytes +90‎ →‎Hepatic Impairment
• curprev 15:5215:52, 18 March 2015‎ Kiran Singh talk contribs‎ 64,591 bytes +94‎ →‎Immunocompromised Patients
• curprev 15:5115:51, 18 March 2015‎ Kiran Singh talk contribs‎ 64,497 bytes +100‎ →‎Race
• curprev 15:5015:50, 18 March 2015‎ Kiran Singh talk contribs‎ 64,397 bytes +78‎ →‎Labor and Delivery
• curprev 15:4715:47, 18 March 2015‎ Kiran Singh talk contribs‎ 64,319 bytes +95‎ →‎Monitoring
• curprev 15:4715:47, 18 March 2015‎ Kiran Singh talk contribs‎ 64,224 bytes +101‎ →‎IV Compatibility
• curprev 15:4615:46, 18 March 2015‎ Kiran Singh talk contribs‎ 64,123 bytes +99‎ →‎Gender
• curprev 15:4315:43, 18 March 2015‎ Kiran Singh talk contribs‎ 64,024 bytes +2,735‎ →‎Structure
• curprev 15:3315:33, 18 March 2015‎ Kiran Singh talk contribs‎ 61,289 bytes +2‎ →‎Guideline-Supported Use
• curprev 15:3215:32, 18 March 2015‎ Kiran Singh talk contribs‎ 61,287 bytes +124‎ →‎Non–Guideline-Supported Use
• curprev 15:3115:31, 18 March 2015‎ Kiran Singh talk contribs‎ 61,163 bytes +116‎ →‎Guideline-Supported Use
• curprev 15:2815:28, 18 March 2015‎ Gerald Chi talk contribs‎ m 61,047 bytes −1‎ →‎Side Effects
• curprev 15:2715:27, 18 March 2015‎ Gerald Chi talk contribs‎ m 61,048 bytes −267‎ No edit summary
• curprev 15:2615:26, 18 March 2015‎ Gerald Chi talk contribs‎ m 61,315 bytes −19‎ →‎How Supplied
• curprev 15:2515:25, 18 March 2015‎ Gerald Chi talk contribs‎ m 61,334 bytes +1‎ →‎Type 2 Diabetes Mellitus
• curprev 15:2415:24, 18 March 2015‎ Gerald Chi talk contribs‎ m 61,333 bytes −78‎ →‎Pharmacology
• curprev 15:2315:23, 18 March 2015‎ Gerald Chi talk contribs‎ m 61,411 bytes −297‎ →‎Pharmacology
• curprev 15:2115:21, 18 March 2015‎ Gerald Chi talk contribs‎ m 61,708 bytes +4‎ →‎Use in Specific Populations
• curprev 15:2015:20, 18 March 2015‎ Gerald Chi talk contribs‎ m 61,704 bytes +4‎ →‎Use in Specific Populations
• curprev 15:2015:20, 18 March 2015‎ Gerald Chi talk contribs‎ m 61,700 bytes −74‎ →‎Contraindications
• curprev 15:1915:19, 18 March 2015‎ Gerald Chi talk contribs‎ m 61,774 bytes +4‎ →‎Adult Indications and Dosage
• curprev 15:1715:17, 18 March 2015‎ Gerald Chi talk contribs‎ m 61,770 bytes +8‎ No edit summary
• curprev 15:1615:16, 18 March 2015‎ Kiran Singh talk contribs‎ 61,762 bytes +7‎ No edit summary
• curprev 15:1415:14, 18 March 2015‎ Kiran Singh talk contribs‎ 61,755 bytes +2‎ →‎Administration
• curprev 15:1415:14, 18 March 2015‎ Kiran Singh talk contribs‎ 61,753 bytes +6‎ →‎Carcinogenesis, Mutagenesis, Impairment of Fertility
• curprev 15:1315:13, 18 March 2015‎ Kiran Singh talk contribs‎ 61,747 bytes +6‎ →‎Carcinogenesis, Mutagenesis, Impairment of Fertility
• curprev 15:1215:12, 18 March 2015‎ Kiran Singh talk contribs‎ 61,741 bytes −1‎ →‎Minor Side Effects
• curprev 15:1215:12, 18 March 2015‎ Kiran Singh talk contribs‎ 61,742 bytes −1‎ →‎Minor Side Effects
• curprev 15:1115:11, 18 March 2015‎ Kiran Singh talk contribs‎ 61,743 bytes +51‎ →‎Patient Information
• curprev 15:0815:08, 18 March 2015‎ Kiran Singh talk contribs‎ 61,692 bytes −38‎ →‎How Supplied
• curprev 15:0715:07, 18 March 2015‎ Kiran Singh talk contribs‎ 61,730 bytes −24‎ →‎How Supplied
• curprev 15:0615:06, 18 March 2015‎ Kiran Singh talk contribs‎ 61,754 bytes −32‎ →‎How Supplied
• curprev 15:0515:05, 18 March 2015‎ Kiran Singh talk contribs‎ 61,786 bytes −48‎ →‎Type 2 Diabetes Mellitus
• curprev 15:0115:01, 18 March 2015‎ Kiran Singh talk contribs‎ 61,834 bytes +2‎ →‎Overdosage
• curprev 15:0015:00, 18 March 2015‎ Kiran Singh talk contribs‎ 61,832 bytes +2‎ →‎Type 2 Diabetes Mellitus
• curprev 15:0015:00, 18 March 2015‎ Kiran Singh talk contribs‎ 61,830 bytes +2‎ →‎Macrovascular Outcomes
• curprev 14:5914:59, 18 March 2015‎ Kiran Singh talk contribs‎ 61,828 bytes −24‎ →‎Primary Hyperlipidemia
• curprev 14:5714:57, 18 March 2015‎ Kiran Singh talk contribs‎ 61,852 bytes +1‎ →‎Vitamin K or Fat-Soluble Vitamin Deficiencies Precautions
• curprev 14:5614:56, 18 March 2015‎ Kiran Singh talk contribs‎ 61,851 bytes +7‎ →‎Primary hyperlipidemia
• curprev 14:5314:53, 18 March 2015‎ Kiran Singh talk contribs‎ 61,844 bytes +7‎ →‎Animal Toxicology and/or Pharmacology
• curprev 14:5214:52, 18 March 2015‎ Kiran Singh talk contribs‎ 61,837 bytes −19‎ →‎Pharmacology
• curprev 14:5014:50, 18 March 2015‎ Kiran Singh talk contribs‎ 61,856 bytes −28‎ →‎Pharmacology
• curprev 14:4814:48, 18 March 2015‎ Kiran Singh talk contribs‎ 61,884 bytes −131‎ →‎Use in Specific Populations
• curprev 14:4414:44, 18 March 2015‎ Kiran Singh talk contribs‎ 62,015 bytes 0‎ →‎Drug Interactions
• curprev 14:4414:44, 18 March 2015‎ Kiran Singh talk contribs‎ 62,015 bytes −78‎ →‎Drug Interactions
• curprev 14:4214:42, 18 March 2015‎ Kiran Singh talk contribs‎ 62,093 bytes +2‎ →‎Postmarketing Experience
• curprev 14:4214:42, 18 March 2015‎ Kiran Singh talk contribs‎ 62,091 bytes −12‎ →‎Clinical Studies Experience
• curprev 14:3714:37, 18 March 2015‎ Kiran Singh talk contribs‎ 62,103 bytes +35‎ →‎Clinical Studies Experience
• curprev 14:3414:34, 18 March 2015‎ Kiran Singh talk contribs‎ 62,068 bytes +23‎ →‎Clinical Studies Experience
• curprev 14:3214:32, 18 March 2015‎ Kiran Singh talk contribs‎ 62,045 bytes −147‎ →‎Clinical Studies Experience
• curprev 14:2314:23, 18 March 2015‎ Kiran Singh talk contribs‎ 62,192 bytes −148‎ →‎Warnings
• curprev 14:1814:18, 18 March 2015‎ Kiran Singh talk contribs‎ 62,340 bytes +3‎ →‎Pediatric Indications and Dosage
• curprev 14:1714:17, 18 March 2015‎ Kiran Singh talk contribs‎ 62,337 bytes −168‎ →‎Adult Indications and Dosage
• curprev 14:1314:13, 18 March 2015‎ Kiran Singh talk contribs‎ 62,505 bytes −11‎ →‎Primary Hyperlipidemia
• curprev 14:0914:09, 18 March 2015‎ Kiran Singh talk contribs‎ 62,516 bytes +8‎ →‎Primary Hyperlipidemia
• curprev 14:0314:03, 18 March 2015‎ Kiran Singh talk contribs‎ 62,508 bytes +24‎ No edit summary

27 July 2014

• curprev 16:5616:56, 27 July 2014‎ GeraldChi talk contribs‎ 62,484 bytes −22‎ No edit summary

24 July 2014

• curprev 15:0615:06, 24 July 2014‎ ShiSheng talk contribs‎ 62,506 bytes +73‎ No edit summary

21 July 2014

• curprev 13:5513:55, 21 July 2014‎ ShiSheng talk contribs‎ 62,433 bytes +55‎ No edit summary

27 June 2014

• curprev 22:3922:39, 27 June 2014‎ Gerald Chi talk contribs‎ m 62,378 bytes −216‎ No edit summary
• curprev 16:0616:06, 27 June 2014‎ Gerald Chi talk contribs‎ m 62,594 bytes −1‎ No edit summary
• curprev 16:0616:06, 27 June 2014‎ Gerald Chi talk contribs‎ m 62,595 bytes −20‎ No edit summary

21 April 2014

• curprev 13:2813:28, 21 April 2014‎ ShiSheng talk contribs‎ 62,615 bytes +62,139‎ No edit summary

27 March 2014

• curprev 18:5018:50, 27 March 2014‎ ShiSheng talk contribs‎ 476 bytes +30‎ No edit summary

26 March 2014

• curprev 20:4720:47, 26 March 2014‎ ShiSheng talk contribs‎ 446 bytes +2‎ No edit summary
• curprev 16:5216:52, 26 March 2014‎ ShiSheng talk contribs‎ 444 bytes −162‎ No edit summary
• curprev 15:5315:53, 26 March 2014‎ ShiSheng talk contribs‎ 606 bytes −30‎ No edit summary
• curprev 15:4615:46, 26 March 2014‎ ShiSheng talk contribs‎ 636 bytes −1,210‎ No edit summary

24 March 2014

• curprev 17:4317:43, 24 March 2014‎ Gerald Chi talk contribs‎ m 1,846 bytes +1‎ No edit summary
• curprev 17:4217:42, 24 March 2014‎ Gerald Chi talk contribs‎ m 1,845 bytes 0‎ No edit summary

20 March 2014

• curprev 21:2021:20, 20 March 2014‎ ShiSheng talk contribs‎ 1,845 bytes +1‎ No edit summary

10 February 2014

• curprev 17:1417:14, 10 February 2014‎ ShiSheng talk contribs‎ 1,844 bytes +459‎ No edit summary

9 August 2012

• curprev 00:0200:02, 9 August 2012‎ WikiBot talk contribs‎ m 1,385 bytes −15‎ Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)

27 September 2011

• curprev 17:2017:20, 27 September 2011‎ Matt Pijoan talk contribs‎ m 1,400 bytes +1,400‎ Protected "Colesevelam": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))